C4 THERAPEUTICS INC (CCCC) Institutional Ownership

CCCC is currently held by 1 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $6.47M based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026.

The largest disclosed holder is Renaissance Technologies LLC, which reported ownership valued at approximately $6.47M in its March 31, 2026 13F filing. Based on current market prices and the latest disclosed share count, Renaissance Technologies LLC's CCCC position is now estimated to be worth approximately $9.65M, representing an estimated gain of +49.05% since the filing period.

Major shareholders tracked on this page include Renaissance Technologies LLC, and other prominent asset managers. Collectively, these investors account for approximately 100% of the total disclosed value among the investors covered in this analysis.

This page tracks institutional ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance to help investors analyze smart money sentiment toward C4 THERAPEUTICS INC (CCCC).

Institutional Ownership Trend

Portfolio quarterInstitutional holdersTotal reported valueTotal shares
Q1 20261$6,474,5732,461,815
Q4 20251$3,060,9281,602,580
Q3 20251$2,080,029936,950
Q2 20251$1,563,2591,093,188
Q1 20251$343,200214,500
Q2 20241$1,086,624235,200
Q1 20241$3,315405,800
Q4 20231$2,400424,700
Q3 20231$666357,988
Q2 20231$1,421516,898
Q1 20231$1,024326,080
Q4 20221$19232,500

Related CCCC Institutional Insights:

CCCC Institutional Ownership and 13F Activity Q1 2026 | InsiderSet